Radiopharmaceutical-gallium 68 dotatate
Ended Awarded Last action
- Contract number
- 36C24824N0388
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI EQ4VSLH8RC33
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $210,000
Award facts
- Contract value 100% obligated
- $210,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Orlovista, FL 32811, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$150,000 | |
| Original award | $360,000 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a $210,000 delivery order to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the supply of Radiopharmaceutical-Gallium 68 Dotatate. This contract is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of March 14, 2025, and performance to be executed in Orlovista, Florida. Gallium 68 Dotatate is a specialized radiopharmaceutical imaging agent used in positron emission tomography (PET) scans for diagnostic and therapeutic applications, particularly in oncology and neuroendocrine imaging. Jubilant Radiopharma, a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, is a leading supplier of radiopharmaceuticals and nuclear medicine products to the VA and other federal healthcare agencies.
This delivery order falls under Jubilant Radiopharma's broader relationship with the VA, which includes multiple Indefinite Delivery Contracts and Blanket Purchase Agreements valued up to $39.8 million across various regional networks. The company has demonstrated consistent capability in supplying critical nuclear medicine isotopes and imaging agents across the VA's nationwide network of facilities serving veterans. Delivery orders such as this one enable VISN 8 to procure essential radiopharmaceuticals to support diagnostic imaging and treatment services across its healthcare facilities. Jubilant Radiopharma's federal contracting history reflects strong performance and reliability in providing time-sensitive medical products that are integral to the VA's nuclear medicine operations.
Quick answers
Who was awarded contract 36C24824N0388?
36C24824N0388 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on March 15, 2024.
How much is contract 36C24824N0388 worth?
The government has obligated $210,000 on 36C24824N0388.
Is contract 36C24824N0388 an order under another contract?
Yes. 36C24824N0388 is a delivery order under 36C24822D0048, an indefinite delivery contract.
Was contract 36C24824N0388 competed?
The extent of competition for 36C24824N0388 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award